189 related articles for article (PubMed ID: 21238463)
1. Gene therapy with hypoxia-inducible factor 1 alpha in skeletal muscle is cardioprotective in vivo.
Czibik G; Gravning J; Martinov V; Ishaq B; Knudsen E; Attramadal H; Valen G
Life Sci; 2011 Mar; 88(11-12):543-50. PubMed ID: 21238463
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection by hypoxia-inducible factor 1 alpha transfection in skeletal muscle is dependent on haem oxygenase activity in mice.
Czibik G; Sagave J; Martinov V; Ishaq B; Sohl M; Sefland I; Carlsen H; Farnebo F; Blomhoff R; Valen G
Cardiovasc Res; 2009 Apr; 82(1):107-14. PubMed ID: 19176596
[TBL] [Abstract][Full Text] [Related]
3. Protecting the heart through delivering DNA encoding for heme oxygenase-1 into skeletal muscle.
Bilbija D; Gravning JA; Haugen F; Attramadal H; Valen G
Life Sci; 2012 Oct; 91(17-18):828-36. PubMed ID: 22917518
[TBL] [Abstract][Full Text] [Related]
4. In vivo remote delivery of DNA encoding for hypoxia-inducible factor 1 alpha reduces myocardial infarct size.
Czibik G; Martinov V; Ruusalepp A; Sagave J; Skare Ø; Valen G
Clin Transl Sci; 2009 Feb; 2(1):33-40. PubMed ID: 20443865
[TBL] [Abstract][Full Text] [Related]
5. Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling.
Dong F; Khalil M; Kiedrowski M; O'Connor C; Petrovic E; Zhou X; Penn MS
Circ Res; 2010 Feb; 106(3):601-10. PubMed ID: 20035082
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.
Kido M; Du L; Sullivan CC; Li X; Deutsch R; Jamieson SW; Thistlethwaite PA
J Am Coll Cardiol; 2005 Dec; 46(11):2116-24. PubMed ID: 16325051
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.
Lakkisto P; Kytö V; Forsten H; Siren JM; Segersvärd H; Voipio-Pulkki LM; Laine M; Pulkki K; Tikkanen I
Eur J Pharmacol; 2010 Jun; 635(1-3):156-64. PubMed ID: 20303947
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α and HIF-2α induce angiogenesis and improve muscle energy recovery.
Niemi H; Honkonen K; Korpisalo P; Huusko J; Kansanen E; Merentie M; Rissanen TT; André H; Pereira T; Poellinger L; Alitalo K; Ylä-Herttuala S
Eur J Clin Invest; 2014 Oct; 44(10):989-99. PubMed ID: 25208310
[TBL] [Abstract][Full Text] [Related]
9. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
[TBL] [Abstract][Full Text] [Related]
10. Activator protein-2α mediates carbon monoxide-induced stromal cell-derived factor-1α expression and vascularization in ischemic heart.
Lin HH; Chen YH; Chiang MT; Huang PL; Chau LY
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):785-94. PubMed ID: 23393395
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound molecular imaging of angiogenesis induced by mutant forms of hypoxia-inducible factor-1α.
Xie J; Liao Y; Yang L; Wu J; Liu C; Xuan W; Li M; Zhang L; Liu Y; Wu P; Bin J
Cardiovasc Res; 2011 Nov; 92(2):256-66. PubMed ID: 21859818
[TBL] [Abstract][Full Text] [Related]
12. In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia.
Ouma GO; Rodriguez E; Muthumani K; Weiner DB; Wilensky RL; Mohler ER
J Vasc Surg; 2014 Mar; 59(3):786-93. PubMed ID: 23850058
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
Du Y; Ge Y; Xu Z; Aa N; Gu X; Meng H; Lin Z; Zhu D; Shi J; Zhuang R; Wu X; Wang X; Yang Z
Med Sci Monit; 2018 Dec; 24():8870-8877. PubMed ID: 30531686
[TBL] [Abstract][Full Text] [Related]
14. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
[TBL] [Abstract][Full Text] [Related]
15. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
Chen JX; Stinnett A
Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
[TBL] [Abstract][Full Text] [Related]
16. Angiogenetic potential of Ad2/Hif-1α/VP16 after regional application in a preclinical pig model of chronic ischemia.
Hinkel R; Lebherz C; Fydanaki M; Wuchrer A; El-Aouni C; Thormann M; Thein E; Kupatt C; Boekstegers P
Curr Vasc Pharmacol; 2013 Jan; 11(1):29-37. PubMed ID: 23391420
[TBL] [Abstract][Full Text] [Related]
17. Effects of transplantation of hypoxia-inducible factor-1α genemodified cardiac stem cells on cardiac function of heart failure rats after myocardial infarction.
Li S; Li S
Anatol J Cardiol; 2018 Dec; 20(6):318-329. PubMed ID: 30504732
[TBL] [Abstract][Full Text] [Related]
18. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat.
Shyu KG; Wang MT; Wang BW; Chang CC; Leu JG; Kuan P; Chang H
Cardiovasc Res; 2002 Jun; 54(3):576-83. PubMed ID: 12031703
[TBL] [Abstract][Full Text] [Related]
19. Combined gene therapy with hypoxia-inducible factor-1α and heme oxygenase-1 for therapeutic angiogenesis.
Bhang SH; Kim JH; Yang HS; La WG; Lee TJ; Kim GH; Kim HA; Lee M; Kim BS
Tissue Eng Part A; 2011 Apr; 17(7-8):915-26. PubMed ID: 20979535
[TBL] [Abstract][Full Text] [Related]
20. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart.
Huang Y; Hickey RP; Yeh JL; Liu D; Dadak A; Young LH; Johnson RS; Giordano FJ
FASEB J; 2004 Jul; 18(10):1138-40. PubMed ID: 15132980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
